Active chimeric antigen receptor T-cell clinical trials for T-cell acute lymphoblastic leukemia/T-cell lymphoblastic lymphoma
| Target . | ClinicalTrials.gov identifier . | Institution/sponsor . | Age restriction . | Status . | Reference . |
|---|---|---|---|---|---|
| CD4 | NCT03829540 | Stony Brook University | 18+ y | Recruiting | 23 |
| CD5 | NCT03081910 | Baylor College of Medicine | <75 y | Recruiting | 18 |
| CD7 | NCT04033302NCT04004637NCT03690011NCT04264078 | Shenzhen Geno-Immune Medical Institute | 6 mo-75 y | Recruiting | — |
| First Affiliated Hospital of Zhengzhou University | 7-70 y | Recruiting | 21 | ||
| Baylor College of Medicine | <75 y | Not yet recruiting | 7 | ||
| Xinqiao Hospital of Chongqing | 2-70 y | Not yet recruiting | — |
| Target . | ClinicalTrials.gov identifier . | Institution/sponsor . | Age restriction . | Status . | Reference . |
|---|---|---|---|---|---|
| CD4 | NCT03829540 | Stony Brook University | 18+ y | Recruiting | 23 |
| CD5 | NCT03081910 | Baylor College of Medicine | <75 y | Recruiting | 18 |
| CD7 | NCT04033302NCT04004637NCT03690011NCT04264078 | Shenzhen Geno-Immune Medical Institute | 6 mo-75 y | Recruiting | — |
| First Affiliated Hospital of Zhengzhou University | 7-70 y | Recruiting | 21 | ||
| Baylor College of Medicine | <75 y | Not yet recruiting | 7 | ||
| Xinqiao Hospital of Chongqing | 2-70 y | Not yet recruiting | — |
Summary of active and completed clinical trials according to www.clinicaltrials.gov as of 1 June 2020.